It was necessary to estimate baseline shed BCMA expression for the PF-06863135 assay to quantitatively delineate the concentration-dependent inhibitory effect of shed BCMAs, which suggested multiple myeloma cells used in the literature may have produced a small amount of shed BCMAs in the in vitro assay system. The gene discussed is TNFRSF17; the disease is AL amyloidosis.